FDA Approved: ELAPRASE — Original Application (Takeda Pharmaceuticals America, Inc.)

View source ↗

Summary

FDA approval of ELAPRASE (idursulfase) under the original application for the treatment of mucopolysaccharidosis type II (Hunter syndrome) by Takeda Pharmaceuti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mucopolysaccharidosis Type Ii

Drugs mentioned

• Elaprase (idursulfase)

Snippet

ORIG AP for ELAPRASE (IDURSULFASE)